122 related articles for article (PubMed ID: 7480380)
1. Distractibility in schizophrenia.
Bergman A; O'Brien J; Osgood G; Cornblatt B
Psychiatry Res; 1995 Jul; 57(2):131-40. PubMed ID: 7480380
[TBL] [Abstract][Full Text] [Related]
2. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.
Miller DD; Rezai K; Alliger R; Andreasen NC
Biol Psychiatry; 1997 Mar; 41(5):550-9. PubMed ID: 9046987
[TBL] [Abstract][Full Text] [Related]
3. Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.
Ahmad SH; Hasan KZ
J Pak Med Assoc; 1977 Apr; 27(4):313-6. PubMed ID: 411951
[TBL] [Abstract][Full Text] [Related]
4. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.
Good KP; Rabinowitz J; Whitehorn D; Harvey PD; DeSmedt G; Kopala LC
Schizophr Res; 2004 May; 68(1):11-9. PubMed ID: 15037335
[TBL] [Abstract][Full Text] [Related]
5. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
Rémillard S; Pourcher E; Cohen H
Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
Mikkelsen EJ
Schizophr Bull; 1982; 8(2):320-32. PubMed ID: 6126001
[TBL] [Abstract][Full Text] [Related]
7. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
Knight RG; Harrison A
N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
Balon R; Berchou R; Zethelius M
Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotic drugs improve cognition in schizophrenia.
Meltzer HY; Sumiyoshi T
Biol Psychiatry; 2003 Feb; 53(3):265-7; author reply 267-8. PubMed ID: 12559661
[No Abstract] [Full Text] [Related]
10. Tardive tourettism after exposure to neuroleptic therapy.
Bharucha KJ; Sethi KD
Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
[TBL] [Abstract][Full Text] [Related]
11. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
[TBL] [Abstract][Full Text] [Related]
12. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
Purdon SE; Malla A; Labelle A; Lit W
J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
Howard JS
Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
[No Abstract] [Full Text] [Related]
15. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
Addington J; Addington D
Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
[No Abstract] [Full Text] [Related]
16. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
Kelwala S; Ban TA; Berney SA; Wilson WH
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
18. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
Schuepbach D; Hill SK; Sanders RD; Hell D; Keshavan MS; Sweeney JA
Schizophr Bull; 2004; 30(4):837-48. PubMed ID: 15957199
[TBL] [Abstract][Full Text] [Related]
19. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.
Donohoe G; Owens N; O'Donnell C; Burke T; Moore L; Tobin A; O'Callaghan E
Eur Psychiatry; 2001 Aug; 16(5):293-8. PubMed ID: 11514132
[TBL] [Abstract][Full Text] [Related]
20. Selective, sustained, and shift in attention in patients with diagnoses of schizophrenia.
Hagh-Shenas H; Toobai S; Makaremi A
Percept Mot Skills; 2002 Dec; 95(3 Pt 2):1087-95. PubMed ID: 12578247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
